Topics in prion cell biology

Current Opinion in Neurobiology

Volumn 9, Issue 5, 1999, Pages 571-577

  Brockes, Jeremy P ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COPPER ION; MUTANT PROTEIN; PRION PROTEIN;

CELL DIVISION; ENDOPLASMIC RETICULUM; NEUROPATHOLOGY; PHENOTYPE; PRION; PRION DISEASE; PRIORITY JOURNAL; PROTEIN INTERACTION; REVIEW; YEAST;

EID: 0032843918     PISSN: 09594388     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-4388(99)00016-1     Document Type: Review

References (65)

1. Prusiner SB Prions. Proc Natl Acad Sci USA. 95:1998;13363-13383.
2. Cohen FE, Prusiner SB Pathologic conformations of prion proteins. Annu Rev Biochem. 67:1998;793-819.
3. Weissmann C, Fischer M, Raeber A, Bueler H, Sailer A, Shmerling D, Rulicke T, Brandner S, Aguzzi A The use of transgenic mice in the investigation of transmissible spongiform encephalopathies. Rev Sci Tech. 17:1998;278-290.
4. Weissmann C Molecular genetics of transmissible spongiform encephalopathies. J Biol Chem. 274:1999;3-6.
5. Prusiner SB The prion diseases. Brain Pathol. 8:1998;499-513.
6. Aguzzi A Grafting mouse brains: from neurocarcinogenesis to neurodegeneration. EMBO J. 17:1998;6107-6114.
7. Prusiner SB, Scott MR, DeArmond SJ, Cohen FE Prion protein biology. Cell. 93:1998;337-348.
8. Raeber AJ, Brandner S, Klein MA, Benninger Y, Musahl C, Frigg R, Roeckl C, Fischer MB, Weissmann C, Aguzzi A Transgenic and knockout mice in research on prion diseases. Brain Pathol. 8:1998;715-733.
9. Hay B, Barry RA, Lieberburg I, Prusiner SB, Lingappa VR Biogenesis and transmembrane orientation of the cellular isoform of the scrapie prion protein. Mol Cell Biol. 7:1987;914-920.
10. Hay B, Prusiner SB, Lingappa VR Evidence for a secretory form of the cellular prion protein. Biochemistry. 26:1987;8110-8115.
11. Lopez CD, Yost CS, Prusiner SB, Myers RM, Lingappa VR Unusual topogenic sequence directs prion protein biogenesis. Science. 248:1990;226-229.
12. Hegde RS, Mastrianni JA, Scott MR, DeFea KA, Tremblay P, Torchia M, DeArmond SJ, Prusiner SB, Lingappa VR A transmembrane form of the prion protein in neurodegenerative disease. Science. 279:1998;827-834. This is a major study clarifying the alternative transmembrane topologies of the prion protein, establishing the pathogenic activity of the ctm form and providing evidence of its presence in the brains of individuals with the A117V mutation.
13. Hegde RS, Lingappa VR Membrane protein biogenesis: regulated complexity at the endoplasmic reticulum. Cell. 91:1997;575-582.
14. Hegde RS, Voigt S, Lingappa VR Regulation of protein topology by trans-acting factors at the endoplasmic reticulum. Mol Cell. 2:1998;85-91. Analysis with proteoliposomes, either minimal or more complex, suggests that the ctm form of PrP is the default option - the presence of transacting factors predisposes towards the sec form, which is the precursor of the familiar GPI-linked form. This raises the possibility that ctm could be generated from wild-type PrP in some contexts; if PrPsc were to influence its formation this would provide an alternative possibility for pathogenesis.
15. Bueler H, Fischer M, Lang Y, Bluethmann H, Lipp HP, DeArmond SJ, Prusiner SB, Aguet M, Weissmann C Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein. Nature. 356:1992;577-582.
16. Manson JC, Clarke AR, Hooper ML, Aitchison L, McConnell I, Hope J 129/Ola mice carrying a null mutation in PrP that abolishes mRNA production are developmentally normal. Mol Neurobiol. 8:1994;121-127.
17. Sayre LM, Perry G, Smith MA Redox metals and neurodegenerative disease. Curr Opin Chem Biol. 3:1999;220-225.
18. Carlton WW Spongiform encephalopathy induced in rats and guinea pigs by cuprizone. Exp Mol Pathol. 10:1969;274-287.
19. Hornshaw MP, McDermott JR, Candy JM, Lakey JH Copper binding to the N-terminal tandem repeat region of mammalian and avian prion protein: structural studies using synthetic peptides. Biochem Biophys Res Commun. 214:1995;993-999.
20. Hornshaw MP, McDermott JR, Candy JM Copper binding to the N-terminal tandem repeat regions of mammalian and avian prion protein. Biochem Biophys Res Commun. 207:1995;621-629.
21. Miura T, Hori-i A, Takeuchi H Metal-dependent alpha-helix formation promoted by the glycine-rich octapeptide region of prion protein. FEBS Lett. 396:1996;248-252.
22. Stockel J, Safar J, Wallace AC, Cohen FE, Prusiner SB Prion protein selectively binds copper(II) ions. Biochemistry. 37:1998;7185-7193.
23. Brown DR, Qin K, Herms JW, Madlung A, Manson J, Strome R, Fraser PE, Kruck T, von Bohlen A, Schulz-Schaeffer Wet al. The cellular prion protein binds copper in vivo. Nature. 390:1997;684-687.
24. 2+ to PrP(58-91).
25. Marcotte EM, Eisenberg D Chicken prion tandem repeats form a stable, protease-resistant domain. Biochemistry. 38:1999;667-676.
26. McKenzie D, Bartz J, Mirwald J, Olander D, Marsh R, Aiken J Reversibility of scrapie inactivation is enhanced by copper. J Biol Chem. 273:1998;25545-25547.
27. Wadsworth JDF, Hill AF, Joiner S, Jackson GS, Clarke AR, Collinge J Strain-specific prion-protein conformation determined by metal ions. Nat Cell Biol. 1:1999;55-59.
28. Brown DR, Besinger A Prion protein expression and superoxide dismutase activity. Biochem J. 334:1998;423-429.
29. Brown DR, Schmidt B, Kretzschmar HA Effects of oxidative stress on prion protein expression in PC12 cells. Int J Dev Neurosci. 15:1997;961-972.
30. Shyng SL, Huber MT, Harris DA A prion protein cycles between the cell surface and an endocytic compartment in cultured neuroblastoma cells. J Biol Chem. 268:1993;15922-15928.
31. Shyng SL, Heuser JE, Harris DA A glycolipid-anchored prion protein is endocytosed via clathrin-coated pits. J Cell Biol. 125:1994;1239-1250.
32. Shyng SL, Moulder KL, Lesko A, Harris DA The N-terminal domain of a glycolipid-anchored prion protein is essential for its endocytosis via clathrin-coated pits. J Biol Chem. 270:1995;14793-14800.
33. 2+.
34. Shmerling D, Hegyi I, Fischer M, Blattler T, Brandner S, Gotz J, Rulicke T, Flechsig E, Cozzio A, von Mering Cet al. Expression of amino-terminally truncated PrP in the mouse leading to ataxia and specific cerebellar lesions. Cell. 93:1998;203-214. Reports that expression of PrP lacking residues 32-121 or 32-134, but not shorter deletions, causes early neuronal death in granular layer neurones. PrP might be implicated in an important trophic pathway.
35. Keshet GI, Ovadia H, Taraboulos A, Gabizon R Scrapie-infected mice and PrP knockout mice share abnormal localization and activity of neuronal nitric oxide synthase. J Neurochem. 72:1999;1224-1231. This interesting analysis points to a specific interaction between PrP and nNOS that targets nNOS to its normal subcellular localization. Abnormal localization in null mice is only observed in adult animals, and this may provide a model for age-dependent pathogenesis.
36. Tuite MF, Lindquist SL Maintenance and inheritance of yeast prions. Trends Genet. 12:1996;467-471.
37. •] are clear recent summaries of the evidence on fungal prions.
38. Kushnirov VV, Ter-Avanesyan MD Structure and replication of yeast prions. Cell. 94:1998;13-16. This short review is particularly interesting for speculations about the propagation and maintenance of the [PSI+] state.
39. •].
40. Lindquist S, DebBurman SK, Glover JR, Kowal AS, Liu JJ, Schirmer EC, Serio TR Amyloid fibres of Sup35 support a prion-like mechanism of inheritance in yeast. Biochem Soc Trans. 26:1998;486-490.
41. Paushkin SV, Kushnirov VV, Smirnov VN, Ter-Avanesyan MD Propagation of the yeast prion-like [psi+] determinant is mediated by oligomerization of the SUP35-encoded polypeptide chain release factor. EMBO J. 15:1996;3127-3134.
42. Patino MM, Liu JJ, Glover JR, Lindquist S Support for the prion hypothesis for inheritance of a phenotypic trait in yeast. Science. 273:1996;622-626.
43. Paushkin SV, Kushnirov VV, Smirnov VN, Ter-Avanesyan MD Interaction between yeast Sup45p (eRF1) and Sup35p (eRF3) polypeptide chain release factors: implications for prion-dependent regulation. Mol Cell Biol. 17:1997;2798-2805.
44. Derkatch IL, Bradley ME, Liebman SW Overexpression of the SUP45 gene encoding a Sup35p-binding protein inhibits the induction of the de novo appearance of the [PSI+] prion. Proc Natl Acad Sci USA. 95:1998;2400-2405.
45. Czaplinski K, Ruiz-Echevarria MJ, Paushkin SV, Han X, Weng Y, Perlick HA, Dietz HC, Ter-Avanesyan MD, Peltz SW The surveillance complex interacts with the translation release factors to enhance termination and degrade aberrant mRNAs. Genes Dev. 12:1998;1665-1677.
46. Derkatch IL, Bradley ME, Zhou P, Liebman SW The PNM2 mutation in the prion protein domain of SUP35 has distinct effects on different variants of the [PSI+] prion in yeast. Curr Genet. 35:1999;59-67.
47. Kochneva-Pervukhova NV, Paushkin SV, Kushnirov VV, Cox BS, Tuite MF, Ter-Avanesyan MD Mechanism of inhibition of Psi+ prion determinant propagation by a mutation of the N-terminus of the yeast Sup35 protein. EMBO J. 17:1998;5805-5810.
48. DePace AH, Santoso A, Hillner P, Weissman JS A critical role for amino-terminal glutamine/asparagine repeats in the formation and propagation of a yeast prion. Cell. 93:1998;1241-1252. Points out the importance of amino terminal Gln/Asn-rich region of Sup35p for amyloid formation. The kinetic analysis of amyloid formation in vitro underlines the importance of rate-determining conformational change rather than nucleation.
49. Chernoff YO, Lindquist SL, Ono B, Inge-Vechtomov SG, Liebman SW Role of the chaperone protein Hsp104 in propagation of the yeast prion-like factor [psi+]. Science. 268:1995;880-884.
50. Newnam GP, Wegrzyn RD, Lindquist SL, Chernoff YO Antagonistic interactions between yeast chaperones Hsp104 and Hsp70 in prion curing. Mol Cell Biol. 19:1999;1325-1333. Reports that maintenance of the prion state depends on the interplay of two different chaperones. This represents a significant step towards identifying intermolecular interactions that are critical for maintenance.
51. Eaglestone SS, Cox BS, Tuite MF Translation termination efficiency can be regulated in saccharomyces cerevisiae by environmental stress through a prion-mediated mechanism. EMBO J. 18:1999;1974-1981. Explores the interrelation of prion state and stress tolerance for [PSI+]. The authors favour models based on alterations in translation termination efficiency and subsequent effects on the stress response. Provides an important additional perspective on the prion phenotype.
52. Taylor KL, Cheng N, Williams RW, Steven AC, Wickner RB Prion domain initiation of amyloid formation in vitro from native Ure2p. Science. 283:1999;1339-1343. Demonstrates that Ure2p prion domain can polymerise to amyloid filaments and recruit native Ure2p. Filaments are congophilic and have high β-sheet content. See also [53].
53. Thual C, Komar AA, Bousset L, Fernandez-Bellot E, Cullin C, Melki R Structural characterization of Saccharomyces cerevisiae prion-like protein Ure2. J Biol Chem. 274:1999;13666-13674.
54. Edskes HK, Gray VT, Wickner RB The [URE3] prion is an aggregated form of Ure2p that can be cured by overexpression of Ure2p fragments. Proc Natl Acad Sci USA. 96:1999;1498-1503. Reports the detection of Ure2p-GFP aggregates in [URE3], but also provides evidence that various Ure2p fragments can cure prion aggregates. This could be the basis for a therapeutic strategy.
55. Fernandez-Bellot E, Guillemet E, Baudin-Baillieu A, Gaumer S, Komar AA, Cullin C Characterization of the interaction domains of Ure2p, a prion-like protein of yeast. Biochem J. 338:1999;403-407.
56. Maddelein ML, Wickner RB Two prion-inducing regions of Ure2p are nonoverlapping. Mol Cell Biol. 19:1999;4516-4524. This progressive deletion analysis of Ure2p reveals a number of regions promoting or inhibiting prion formation. The idea that the amino-terminal domain is sufficient as well as necessary in this context appears too simplistic.
57. Coustou V, Deleu C, Saupe S, Begueret J The protein product of the het-s heterokaryon incompatibility gene of the fungus Podospora anserina behaves as a prion analog. Proc Natl Acad Sci USA. 94:1997;9773-9778.
58. Silar P, Daboussi MJ Non-conventional infectious elements in filamentous fungi. Trends Genet. 15:1999;141-145. Presents analysis of potential prion phenomena in filamentous fungi. Particularly valuable for analysis of older literature on modifications of hyphal morphology which propagate through cultures.
59. Korth C, Stierli B, Streit P, Moser M, Schaller O, Fischer R, Schulz-Schaeffer W, Kretzschmar H, Raeber A, Braun Uet al. Prion (PrPSc)-specific epitope defined by a monoclonal antibody. Nature. 390:1997;74-77.
60. Vorberg I, Buschmann A, Harmeyer S, Saalmuller A, Pfaff E, Groschup MH A novel epitope for the specific detection of exogenous prion proteins in transgenic mice and transfected murine cell lines. Virology. 255:1999;26-31.
61. Zanusso G, Liu D, Ferrari S, Hegyi I, Yin X, Aguzzi A, Hornemann S, Liemann S, Glockshuber R, Manson JCet al. Prion protein expression in different species: analysis with a panel of new mAbs. Proc Natl Acad Sci USA. 95:1998;8812-8816.
62. Peretz D, Williamson RA, Matsunaga Y, Serban H, Pinilla C, Bastidas RB, Rozenshteyn R, James TL, Houghten RA, Cohen FEet al. A conformational transition at the N terminus of the prion protein features in formation of the scrapie isoform. J Mol Biol. 273:1997;614-622.
63. sc-specific reagents. An important pointer for continuing attempts to derive specific antibodies.
64. Kascsak RJ, Rubenstein R, Merz PA, Tonna-DeMasi M, Fersko R, Carp RI, Wisniewski HM, Diringer H Mouse polyclonal and monoclonal antibody to scrapie-associated fibril proteins. J Virol. 61:1987;3688-3693.
65. sc.